• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Emerging Therapies: Pleiotropic Multi-target Drugs to Treat Stroke Victims.新兴疗法：用于治疗中风患者的多效多靶点药物
Transl Stroke Res. 2011 Jun 1;2(2):129-35. doi: 10.1007/s12975-011-0074-4.
2
Pathophysiology, treatment, and animal and cellular models of human ischemic stroke.人类缺血性中风的病理生理学、治疗方法以及动物和细胞模型。
Mol Neurodegener. 2011 Jan 25;6(1):11. doi: 10.1186/1750-1326-6-11.
3
Cell Therapies under Clinical Trials and Polarized Cell Therapies in Pre-Clinical Studies to Treat Ischemic Stroke and Neurological Diseases: A Literature Review.临床研究中的细胞治疗和临床前研究中的极化细胞治疗治疗缺血性中风和神经疾病：文献综述。
Int J Mol Sci. 2020 Aug 27;21(17):6194. doi: 10.3390/ijms21176194.
4
Therapeutic Options in Alzheimer's Disease: From Classic Acetylcholinesterase Inhibitors to Multi-Target Drugs with Pleiotropic Activity.阿尔茨海默病的治疗选择：从经典的乙酰胆碱酯酶抑制剂到具有多效活性的多靶点药物。
Life (Basel). 2024 Nov 26;14(12):1555. doi: 10.3390/life14121555.
5
Secondary prevention of stroke: Pleiotropic effects of optimal oral pharmacotherapy.中风的二级预防：最佳口服药物治疗的多效性作用
Exp Ther Med. 2012 Jul;4(1):3-7. doi: 10.3892/etm.2012.560. Epub 2012 Apr 24.
6
The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies.脂质修饰干预的多效性：探索传统和新型降血脂疗法
Metabolites. 2024 Jul 17;14(7):388. doi: 10.3390/metabo14070388.
7
CD36: a multi-modal target for acute stroke therapy.CD36：急性中风治疗的多模式靶点。
J Neurochem. 2009 May;109 Suppl 1(Suppl 1):126-32. doi: 10.1111/j.1471-4159.2009.05801.x.
8
Emerging pharmacological therapies for ARDS: COVID-19 and beyond.急性呼吸窘迫综合征的新兴药理学治疗方法：COVID-19 及其他。
Intensive Care Med. 2020 Dec;46(12):2265-2283. doi: 10.1007/s00134-020-06141-z. Epub 2020 Jul 11.
9
Drug-like property profiling of novel neuroprotective compounds to treat acute ischemic stroke: guidelines to develop pleiotropic molecules.新型神经保护化合物治疗急性缺血性脑卒中的类药性特征分析：开发多效分子的指南。
Transl Stroke Res. 2013 Jun;4(3):328-42. doi: 10.1007/s12975-012-0200-y.
10
Repurposing of Approved Cardiovascular Drugs against Ischemic Cerebrovascular Disease by Disease-Disease Associated Network-Assisted Prediction.基于疾病关联网络辅助预测的已批准心血管药物用于缺血性脑血管疾病的再利用研究
Chem Pharm Bull (Tokyo). 2019 Jan 1;67(1):32-40. doi: 10.1248/cpb.c18-00634. Epub 2018 Nov 8.

引用本文的文献

1
How to Pick a Neuroprotective Drug in Stroke Without Losing Your Mind?如何在不发疯的情况下挑选治疗中风的神经保护药物？
Life (Basel). 2025 May 30;15(6):883. doi: 10.3390/life15060883.
2
NPD1 Plus RvD1 Mediated Ischemic Stroke Penumbra Protection Increases Expression of Pro-homeostatic Microglial and Astrocyte Genes.NPD1 加 RvD1 介导的缺血性中风半影保护增加了促内稳态小胶质细胞和星形胶质细胞基因的表达。
Cell Mol Neurobiol. 2023 Oct;43(7):3555-3573. doi: 10.1007/s10571-023-01363-3. Epub 2023 Jun 4.
3
Synergistic Neuroprotection by a PAF Antagonist Plus a Docosanoid in Experimental Ischemic Stroke: Dose-Response and Therapeutic Window.PAF 拮抗剂与 Docosanoid 在实验性缺血性中风中的协同神经保护作用：剂量反应和治疗窗。
J Stroke Cerebrovasc Dis. 2022 Aug;31(8):106585. doi: 10.1016/j.jstrokecerebrovasdis.2022.106585. Epub 2022 Jun 17.
4
Small molecule neurolysin activators, potential multi-mechanism agents for ischemic stroke therapy.小分子神经溶素激活剂，用于缺血性中风治疗的潜在多机制药物。
Expert Opin Ther Targets. 2022 May;26(5):401-404. doi: 10.1080/14728222.2022.2077190. Epub 2022 May 19.
5
Elucidating the Synergistic Effect of Multiple Chinese Herbal Prescriptions in the Treatment of Post-stroke Neurological Damage.阐明多种中药复方治疗中风后神经损伤的协同作用。
Front Pharmacol. 2022 Mar 9;13:784242. doi: 10.3389/fphar.2022.784242. eCollection 2022.
6
The Quinazoline Otaplimastat (SP-8203) Reduces the Hemorrhagic Transformation and Mortality Aggravated after Delayed rtPA-Induced Thrombolysis in Cerebral Ischemia.喹唑啉类 Otaplimastat（SP-8203）可减少延迟 rtPA 诱导的溶栓后缺血性脑卒中的出血性转化和死亡率加重。
Int J Mol Sci. 2022 Jan 26;23(3):1403. doi: 10.3390/ijms23031403.
7
Top Priorities for Cerebroprotective Studies-A Paradigm Shift: Report From STAIR XI.防治脑损伤研究的当务之急：从 STAIR XI 报告看范式转变。
Stroke. 2021 Aug;52(9):3063-3071. doi: 10.1161/STROKEAHA.121.034947. Epub 2021 Jul 22.
8
Stroke Treatment With PAR-1 Agents to Decrease Hemorrhagic Transformation.使用PAR-1拮抗剂治疗中风以减少出血性转化。
Front Neurol. 2021 Mar 15;12:593582. doi: 10.3389/fneur.2021.593582. eCollection 2021.
9
Neuroprotective effect of chlorogenic acid in global cerebral ischemia-reperfusion rat model.绿原酸对全脑缺血再灌注大鼠模型的神经保护作用。
Naunyn Schmiedebergs Arch Pharmacol. 2019 Oct;392(10):1293-1309. doi: 10.1007/s00210-019-01670-x. Epub 2019 Jun 12.
10
A11, a novel diaryl acylhydrazone derivative, exerts neuroprotection against ischemic injury in vitro and in vivo.A11，一种新型二芳基酰腙衍生物，在体外和体内发挥对缺血性损伤的神经保护作用。
Acta Pharmacol Sin. 2019 Feb;40(2):160-169. doi: 10.1038/s41401-018-0028-4. Epub 2018 Jun 20.

本文引用的文献

1
Dipyridamole Treatment Prior to Stroke Onset: Examining Post-stroke Cerebral Circulation and Outcome in Rabbits.吡拉西坦治疗脑卒中发作前：研究兔脑卒中后脑血管循环和转归。
Transl Stroke Res. 2011 Jun;2(2):186-94. doi: 10.1007/s12975-010-0062-0. Epub 2011 Jan 11.
2
Sonothrombolysis: an emerging modality for the treatment of acute ischemic and hemorrhagic stroke.超声溶栓：一种治疗急性缺血性和出血性中风的新兴方法。
Transl Stroke Res. 2011 Jun;2(2):159-70. doi: 10.1007/s12975-011-0077-1. Epub 2011 Apr 15.
3
De-Risking of Stilbazulenyl Nitrone (STAZN), a Lipophilic Nitrone to Treat Stroke Using a Unique Panel of In Vitro Assays.使用独特的体外检测试剂盒降低脂溶性硝酮 Stilbazulenyl Nitrone（STAZN）治疗中风的风险。
Transl Stroke Res. 2011 Jun;2(2):209-17. doi: 10.1007/s12975-011-0071-7.
4
Minocycline development for acute ischemic stroke.米诺环素治疗急性缺血性脑卒中。
Transl Stroke Res. 2011 Jun 1;2(2):202-8. doi: 10.1007/s12975-011-0072-6.
5
Are Underlying Assumptions of Current Animal Models of Human Stroke Correct: from STAIRs to High Hurdles?目前的人类中风动物模型的基本假设是否正确：从 STAIRs 到高障碍？
Transl Stroke Res. 2011 Jun;2(2):138-43. doi: 10.1007/s12975-011-0067-3. Epub 2011 Feb 12.
6
Continuous monitoring of changes in plasma nitrite following cerebral ischemia in a rabbit embolic stroke model.兔栓塞性中风模型脑缺血后血浆亚硝酸盐变化的连续监测。
Transl Stroke Res. 2011 Jun;2(2):218-26. doi: 10.1007/s12975-011-0073-5.
7
CeeTox™ Analysis of CNB-001 a Novel Curcumin-Based Neurotrophic/Neuroprotective Lead Compound to Treat Stroke: Comparison with NXY-059 and Radicut.CNB-001 的 CeeTox 分析——一种新型姜黄素类神经营养/神经保护先导化合物，用于治疗中风：与 NXY-059 和 Radicut 的比较。
Transl Stroke Res. 2011 Mar;2(1):51-9. doi: 10.1007/s12975-010-0034-4.
8
Reperfusion and outcomes in Penumbra vs. systemic tissue plasminogen activator clinical trials.Penumbra 与系统组织型纤溶酶原激活物临床试验中的再灌注和结局。
Int J Stroke. 2011 Apr;6(2):118-22. doi: 10.1111/j.1747-4949.2010.00559.x. Epub 2010 Dec 23.
9
Vascular mechanisms in the pathogenesis of stroke.血管机制在中风发病机制中的作用。
Curr Hypertens Rep. 2011 Jun;13(3):200-7. doi: 10.1007/s11906-011-0195-x.
10
Reperfusion therapies for acute ischemic stroke: current pharmacological and mechanical approaches.急性缺血性脑卒中的再灌注治疗：当前的药理学和机械学方法。
Stroke. 2011 Jan;42(1 Suppl):S16-9. doi: 10.1161/STROKEAHA.110.598763. Epub 2010 Dec 16.

Emerging Therapies: Pleiotropic Multi-target Drugs to Treat Stroke Victims.

作者信息

Lapchak Paul A

机构信息

Translational Research, Cedars-Sinai Medical Center, Department of Neurology, Burns and Allen Research Institute, Davis Research Building, Room D-2091, 110 N. George Burns Road, Los Angeles, CA 90048, USA.

出版信息

Transl Stroke Res. 2011 Jun 1;2(2):129-35. doi: 10.1007/s12975-011-0074-4.

DOI:10.1007/s12975-011-0074-4
PMID:21666853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3109659/
Abstract
摘要